Sphere Entertainment's stock has soared 39% in three months, with a 105% annual return, forcing Wall Street to re-evaluate the future of its immersive live experiences. Analysts debate if the current price still offers value or if the market has already priced in a perfect show.
Expedia Group's latest quarterly results, surpassing expectations across key metrics, have reignited investor interest and a fierce debate over its true worth. While analysts see room for growth, looming challenges in travel demand and disruptive AI search tools cloud the horizon.
PennyMac Financial Services reported Q4 2025 net income of $106.8 million, declaring a $0.30 per share dividend. While full-year profits grew on higher loan production, the quarter was pressured by a sharp decline in mortgage servicing income due to accelerated prepayments, highlighting the volatility inherent in its dual business model.
First Hawaiian Bank (FHB) shares have captured investor interest following a period of mixed performance, trading at $26.55. While recent daily declines contrast with solid monthly and quarterly gains, analysts debate whether the stock's current discount to intrinsic value represents a buying opportunity or reflects underlying economic risks.
Gap's shares have soared over 100% in three years, fueled by a remarkable operational turnaround. But as the stock hovers near $28, investors are asking: does the current price fairly reflect the future, or has the market run ahead of itself? A deep dive into valuation metrics reveals a mixed picture.
Standex International's fiscal Q2 results showcase robust organic growth and record order intake, driven by a multi-year strategic pivot towards new product innovation and high-growth markets like grid infrastructure and defense.
Hilltop Holdings capped off 2025 with a 46% surge in net income, fueled by a steeper yield curve and disciplined cost management across its banking and securities units. While the mortgage division remains under pressure, executives point to a robust loan pipeline and shareholder returns as signs of resilience heading into 2026.
Novo Nordisk's newly launched oral GLP-1 drug, amycretin, has seen explosive initial demand in the U.S., potentially setting the stage for a significant financial turnaround and stock rally after a challenging previous year.
Verizon shares surged nearly 12% after quarterly results and guidance exceeded expectations, highlighting robust subscriber gains and a massive new share repurchase program aimed at rewarding investors.
Ontario's regulated online gambling sector capped a record-breaking year with a strong December performance, generating over $425 million in monthly revenue and pushing the annual total past the $4 billion mark, as the province's market continues to outpace growth seen in many U.S. states.
Well-intentioned financial guidance from previous generations often fails to account for today's economic realities. From home ownership to savings accounts, we examine the advice that hasn't aged well and what you should consider instead.
Toyota Motor posts record annual sales of 10.5 million vehicles, solidifying its global leadership. As its shares show strong long-term gains, investors are weighing future growth potential against tariff pressures and valuation concerns.
Shares of the alternative asset manager have retreated sharply from recent highs, prompting investors to question whether the stock's premium valuation remains justified. We examine the key metrics and what the pullback might signal.
Despite reporting stronger annual profits and lower charge-offs, LendingClub's stock faces significant pressure following its shift to fair value accounting and the launch of new growth initiatives like home improvement loans.
Viking Holdings (VIK) shares have surged over 40% in the past year, but analysts are divided on whether the luxury cruise operator is fairly valued or poised for a correction. We examine the conflicting signals from recent price action and intrinsic value models.
After years of share price decline, Nomad Foods (NOMD) appears deeply undervalued by traditional metrics. But does the market know something the models don't? We examine the numbers and the narratives behind the frozen food giant's valuation.
As Tilray Brands' stock languishes near multi-year lows, a deep dive into its valuation metrics suggests a significant discount. But with the cannabis sector facing headwinds, is this a genuine opportunity for investors, or a sign of deeper troubles?
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
Littelfuse shares rallied sharply following the closure of its Basler Electric acquisition, alongside stronger-than-expected Q1 2026 sales guidance and a new dividend declaration, despite posting a significant net loss for Q4 2025.
Tetra Tech's stock has surged following strong Q1 results, raised guidance, and enhanced capital returns. While analysts see further upside, questions linger over contract risks and a premium valuation.
